Skip to Content

Par C210 (Fenofibric acid delayed-release 135 mg)

Pill imprint Par C210 has been identified as Fenofibric acid delayed-release 135 mg.

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substance Act (CSA).

Fenofibric acid delayed-release 135 mg Par C210
Discount Card Promo
Fenofibric acid delayed-release
Imprint:
Par C210
Strength:
135 mg
Color:
Blue & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Par Pharmaceutical Companies, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide